Polycomb group proteins control a hierarchy of gene expression during the differentiation of stem cells. In this issue, Ezhkova et al. (2009) show that repression mediated by Polycomb proteins controls the timing of differentiation of precursor cells of the epidermal lineage.
test (depression-like behavior). Importantly, both cellular and behavioral phenotypes could be normalized by treating the mice with a GSK3β inhibitor. These findings support an emerging view that dysfunction of adult hippocampal neurogenesis may contribute to manifestations of psychiatric disease during adulthood (Duan et al., 2007 ). An intriguing hypothesis is that defects in embryonic neuronal development predispose individuals to neuropsychiatric illness, whereas dysfunctional neurogenesis in the adult (which is dynamically regulated by the existing neuronal circuitry) pushes the individual over the threshold, resulting in the full manifestation of neuropsychiatric disease. Future genetic studies using conditional knockout mice to manipulate specific cell types in the adult brain will help to clarify this model. With many exciting new studies underway, the next chapter in the saga of DISC1 and its role in neural development should soon be here.
Pluripotent cells in the early embryo have the capacity to differentiate into any cell type to produce all the tissues of the adult body but are prevented from doing so until the appropriate time and place. Initially, the suppression of all the various potential pathways of differentiation is transient, but once a single pathway of differentiation has been selected, this suppression is made permanent. In embryonic stem (ES) cells nearly all genes involved in differentiation are bound by Polycomb-repressive complexes 1 and 2 (PRC1 and PRC2) and are marked by histone H3 lysine 27 trimethylation (H3K27me3) (Boyer et al., 2006) . This discovery suggests that mechanisms involving Polycomb group (PcG) proteins prevent indiscriminate differentiation of ES cells (Figure 1) . But experiments in which PcG gene function is knocked down show that the picture is more complicated at later stages of cell commitment. In this issue of Cell, Ezhkova et al. (2009) show that the loss of PcG function in epidermal precursor cells specifically derepresses genes relevant to epidermal differentiation, thereby accelerating the rate of normal maturation.
In ES cells, genes involved in differentiation that are bound by PcG complexes not only bear the repressive H3K27me3 mark but also are trimethylated at lysine 4 of histone H3 (H3K4me3), a mark associated with transcriptional activity. The simultaneous presence of both repressive and active chromatin marks, called the bivalent state (Bernstein et al., 2006) , is in fact accompanied by at least some transcriptional activity, suggesting that it signifies an uneasy equilibrium between opposing forces. Indeed, multiple reports have shown that when PcG function is knocked down in ES cells, the expression of genes controlling many differentiation pathways is partially derepressed. Embryos deficient in Ezh2, the histone methyltransferase component of PRC2, fail to progress beyond implantation and do not allow the establishment of ES cells (O'Carroll et al., 2001) .
Is PcG repression then essential to maintain the pluripotent state? Surprisingly, it is possible to generate relatively stable ES cells lacking Suz12 or Eed, which are essential components of the PRC2 complex, perhaps suggesting that Ezh2 has additional functions beyond the PRC2 complex. Although these cells are depleted of H3K27me3 and express higher levels of differentia- tion genes, they continue to proliferate and can initiate multiple differentiation programs (Montgomery et al., 2005; Pasini et al., 2007) . Although PcGbased mechanisms are not essential for self-renewal, they are necessary for proper differentiation. In their absence, gastrulation-specific genes are not activated and, when PcG-deficient ES cells are induced to differentiate, pluripotency genes such as Oct4 and Nanog are not turned off, leading to a failure to activate genes involved in terminal differentiation. Ezhkova et al. (2009) now make important progress in clarifying the role of PcG repression in epidermal lineage differentiation. Differentiating epidermal cells appear in the 14-day-old mouse embryo and arise from a layer of precursors, called basal cells, which are attached to the basement membrane. Basal cells continue to divide, producing a series of suprabasal layers. As these cell layers mature, they progressively lose the capacity to proliferate and activate a program of differentiation genes, culminating in an outermost layer consisting of dead cells. The authors show that, like ES cells, basal cells are rich in Ezh2 and other PcG proteins, but as they differentiate Ezh2 expression is turned off and the cells exit the cell cycle. To circumvent the problem of establishing Ezh2 null ES cells, the authors constructed an Ezh2 gene the excision of which is activated under control of a basal cellspecific promoter. Despite the global loss of the H3K27me3 mark that follows this conditional inactivation in the basal cells, "master" genes corresponding to other differentiation pathways do not become derepressed, although they normally bind to PcG proteins. In contrast, Ezh2-deficient basal cells proliferate more slowly and display precocious expression of genes associated with terminal epidermal differentiation, accelerating the normal maturation process of epidermal development. Thus, loss of PcG function in basal cells selectively derepresses genes relevant to epidermal differentiation. Among these are Ink4A and B, which encode inhibitors of cyclin-dependent kinases and therefore block entry into S phase and arrest cellcycle progression. PcG repression in this process appears to control the balance between the proliferative layer of precursor cells and the nonproliferating layers of differentiating cells. Ezhkova et al. show that the entire program of epidermal differentiation is simply unrolled by the gradual turndown of PcG proteins and their repressive effects. In this account, there is no evidence that Ezh2 plays a direct role in gene activation (as hypothesized by Pasini et al., 2007) . Loss of Ezh2 is followed by loss of H3K27me3. The ensuing derepression of Ink4A/B brings about cell-cycle arrest. AP1 transcription factors, which are the major effectors of the expression of epidermal genes associated with terminal differentiation, are already present in basal cells but are prevented from binding to their target genes. Loss of PcG function makes these binding sites available and thereby permits the expression of terminal differentiation genes.
Polycomb Repression under the skin
A basic difference between this account and other models for PcG function in ES cells lies in the repression of the "master" differentiation genes. Earlier work (such as Pasini et al., 2007 and Stock et al., 2007) has shown that loss of PcG function in ES cells causes increased expression of differentiation genes and a failure to shut off pluripotency genes when the cells are induced to differentiate. However, differentiation genes are not fully derepressed, which in principle would make it impossible to maintain PcG-deficient ES cells. Yet such cells have been produced in several laboratories. It is possible that ES cell lines differ from one another in this respect or that the way they are rendered PcG-deficient may cause selection for alternative pathways of repression.
More likely, however, differentiation genes in ES cells are controlled by an equilibrium of regulatory factors to which PcG-based mechanisms contribute a degree of stabilization. That PcG proteins by themselves do not completely repress differentiation genes is shown by the bivalent chromatin state and by the appreciable level of transcription that this state sustains. There is an increasing appreciation that PcG repression of gene expression is dynamic and not always incompatible with a degree of transcriptional activity. It is possible in fact that the level of transcription in the bivalent state is important for preventing DNA methylation and long-term silencing of differentiation genes, thus helping to maintain the pluripotent state. In the work of Ezhkova et al., the conditional knockout of Ezh2 occurs in the basal keratinocytes, cells that have already entered the epidermal pathway. In these cells, the genes controlling the pluripotent state as well as other differentiation pathways have been silenced by PcGindependent processes. Perhaps a model for this can be found in the regulation of the Oct4 gene: when ES cells are induced to differentiate, the Oct4 gene promoter is bound by transcriptional repressors, which recruit the H3K9 methyltransferase G9a, in turn leading to de novo DNA methylation and permanent shutdown of its expression (Feldman et al., 2006; Epsztejn-Litman et al., 2008) . In this view, PcG-based mechanisms emerge as the flexible dynamic field artillery of genomic repression as opposed to the heavy artillery represented by DNA methylation.
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